BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1365543)

  • 1. Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Raab-Traub N
    Infect Agents Dis; 1992 Aug; 1(4):173-84. PubMed ID: 1365543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
    Pathmanathan R; Prasad U; Sadler R; Flynn K; Raab-Traub N
    N Engl J Med; 1995 Sep; 333(11):693-8. PubMed ID: 7637746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and nasopharyngeal cancer.
    Schuster V; Pukrop T
    N Engl J Med; 1996 Jan; 334(2):122-3. PubMed ID: 8531953
    [No Abstract]   [Full Text] [Related]  

  • 4. Epstein-Barr virus--increasing evidence of a link to carcinoma.
    Kieff E
    N Engl J Med; 1995 Sep; 333(11):724-6. PubMed ID: 7637753
    [No Abstract]   [Full Text] [Related]  

  • 5. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
    Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
    Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S; Yao K; Cao Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Sun N; Chen X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and nasopharyngeal carcinoma.
    Raab-Traub N
    Semin Cancer Biol; 1992 Oct; 3(5):297-307. PubMed ID: 1335793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and nasopharyngeal cancer.
    Meisler AI
    N Engl J Med; 1996 Jan; 334(2):122; author reply 122-3. PubMed ID: 8531952
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus infection in non-carcinomatous gastric epithelium.
    Yanai H; Takada K; Shimizu N; Mizugaki Y; Tada M; Okita K
    J Pathol; 1997 Nov; 183(3):293-8. PubMed ID: 9422984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies.
    Busson P; Keryer C; Ooka T; Corbex M
    Trends Microbiol; 2004 Aug; 12(8):356-60. PubMed ID: 15276610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epstein-Barr, hepatitis B and hepatitis C virus infections and their oncogenic potentials].
    Jovanović J; Brkić S; Klasnja B; Fabri M
    Med Pregl; 1997; 50(11-12):499-504. PubMed ID: 9471511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
    Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
    Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma.
    Ambinder RF; Robertson KD; Moore SM; Yang J
    Semin Cancer Biol; 1996 Aug; 7(4):217-26. PubMed ID: 8946606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic value of Epstein-Barr virus diagnosis].
    Bauer G
    Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.